Barclays
IQMDW

Barclays’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Barclays’s Portfolio IQMDW Stock Details IQMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-387,801
Closed -$4.15K – 5491
2022
Q4 		$4.15K Buy
+387,801
New +$11.7K ﹤0.01% 5018

Other funds holding IQMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Barclays's IQMDW Position: Q1 2023 in Review

Barclays sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q1 2023, closing a stake of 387,801 shares — an estimated $4.15K sold.

Barclays first reported a position in IQMDW in Q4 2022 and held it in 1 quarter. The position peaked at $4.15K in Q4 2022. 49 funds tracked by Wall St. Rank hold IQMDW as of Q1 2023.

  • Barclays reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Barclays sold 387,801 Intelligent Medicine Acquisition Corp. Warrant shares in Q1 2023, an estimated $4.15K.
  • Barclays first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2022 and held it in 1 quarter.
  • Barclays's Intelligent Medicine Acquisition Corp. Warrant position peaked at $4.15K in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.